In 2017, women may benefit from these interesting health technologies

Release date: 2016-12-30

Today, more and more startups realize that women and men have different health needs. As a result, many companies are developing new products and services to address women's unique births, contraception and physical condition. Recently, MIT Technology Review reported some of the most interesting women's health technologies under development.

Let breast reconstruction no longer suffer

As the rate of double mastectomy increases, more women need to make a decision whether to perform breast reconstruction after surgery. For decades, the reconstruction process has required the use of a tissue expander to enlarge the breast tissue and then implant the prosthesis. The dilator needs a needle, which is painful and inconvenient. Today, a patient-controlled needle-free device can also be used for breast reconstruction, which uses a small amount of carbon dioxide to expand tissue. This device is currently in clinical trials and is awaiting FDA approval.

Diagnosis of endometriosis

Dot Laboratories in San Francisco, USA, has developed a test for endometriosis, a painful condition in which tissue that should be present in the uterus grows outside the uterus. In the female population, the incidence of endometriosis is about 10%, and often causes infertility. Often, the only way to diagnose a disease is invasive surgery. Heather Bowerman of Dot Laboratories hopes to change this. Her company has developed a blood test that is scheduled to be launched in mid-2017.

Uber in the contraceptive world

In the United States, contraception is a nuisance for women because oral contraceptives also require prescription. For women who suddenly find that the pill is eaten up, the startup Nurx can help. Customers can log in to Nurx's desktop platform or download an app, enter personal health information, and choose the type of contraception she likes. Then Nurx's doctor will contact her, the company will prescribe the drug delivery room and arrange delivery. Currently, Nurx can be delivered to California, New York, Washington and other regions, and plans to expand to other regions.

Collecting the cervical smear yourself

Although most women who have purchased insurance can regularly receive Pap smear tests to screen for cervical abnormalities, many women still miss it because of the variety of tests that may be too embarrassing. Eve Medical, based in Toronto, Canada, has developed a do-it-yourself kit that allows women to take samples of themselves to detect chlamydia, gonorrhea and human papillomavirus (HPV). After the woman prepares the swab, she can send it back to the company for analysis. Currently, the company sells this product online to Canadian residents.

Detection of fertility by saliva

Katie Brenner, a postdoctoral fellow at the University of Wisconsin-Madison, was disappointed when she tried various fertility testing products on the market and created BluDiagnostics. The company is developing a saliva-based testing device that measures women's hormone levels. In this way, women can predict ovulation, diagnose pregnancy, and identify hormone problems that cause female infertility. If clinical trials prove that the technology is effective, it is expected to replace hormone testing that is usually required in the clinic.

Source: Biopass

APIs & Intermediates

Intermediates of Cladribine, Carvedilol, Lurasidone, olmesartan, Risedronate Sodium, Atazanavir, Saxagliptin, Dabigatran,Dapoxetine,Cefixime,Ceftaroline fosamil and etc.

In the short span of time, we have emerged as most promising pharmaceutical intermediates manufacturers, chemical intermediates and bulk drug intermediates suppliers. Our consistent supply, quality products and dedication towards clients have opened up many international avenues for our growth.

In addition, the company also can follow the customer's product needs custom synthesis services

MAIN API PRODUCTS USP/BP

Major Pharmaceutical Intermediates

Items Descripation	Structure	Application
MICA ESTER CAS No: 246035-38-1 Purity: ≥98%		For Cefixime
EHATA CAS No: 64485-82-1 Purity: ≥98%		For Ceftazidine
2-Chloroadenine CAS No: 1839-18-5		For Cladribine, Fludarabine et al
Bicyclo(2,2,1)Heptane-2,3-di-exo-carboximide CAS No: 14805o-29-9		For Lurasidne
(R,R)-1,2-Bis(methanesulfonyloxy methyl)Cyclohexane CAS No: 186204-35-3		For Lurasidone
3-(Piperazin-1-yl)benzol[d] isothiazole CAS No: 87691-87-0		For Lurasidone
Trityl olmesartan CAS No: 144690-92-6 Purity: ≥98%		For olmesartan
3-Acetyl Pyridine CAS No: 350-03-8		For Risedronate Sodium
3-(AceticAcid)pyridine HCL CAS No: 6419-36-9		For Risedronate Sodium
Risedronic Acid CAS No: 105462-24-6		For Risedronate Sodium
3-Hydroxy-1-adamantyl-D-Glycine CAS No: 709031-29-8		For Saxagliptin
(1s,3s,5s)-3-(aminocarbonyl)-2-azabicyclo(3,1,0) hexane-2-carboxylic acid tert-butyl ester CAS No: 361440-67-7		For Saxagliptin
(S)-N-Boc-3- hydroxy-adamantylglycine CAS No: 361442-00-4		For Saxagliptin
2-Azabicyclo[3.1.0] hexane-3-carbonitrile, (1s,3s,5s)- CAS No: 866083-42-3		For Saxagliptin
Ethyl 3-(pyridin-2-ylamino) propanoate CAS No: 103041-38-9		For Dabigatran
N-(4-Cyanophenyl) glycine CAS No: 42288-26-6		For Dabigatran
4-methylamino-3-nitrobenzoic Acid CAS No: 41263-74-5		For Dabigatran
S-3-Amino-3-phenylpropanoic acid ethyl ester HCL CAS No: 167834-24-4		For Dapoxetine
(S)-3-Amino-3-Phemylpropan -1-ol CAS No: 82769-76-4		For Dapoxetine
(S)-3-Dimethylamino-3-Phemylpropanol CAS No: 82769-75-3		For Dapoxetine
4-{4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butynil}-α,α-dimethyl benzene acetic acid CAS No: 832088-68-3		For Fexofenadine HCl
Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate CAS No:154477-54-0		For Fexofenadine HCl
5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone CAS No 461432-22-4		For Dapagliflozin
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether CAS No :461432-23-5		For Dapagliflozin

Mica Ester,Pharma Intermediates,Ciprofloxacin Hcl Uses,Active Pharmaceutical Ingredients

NINGBO VOICE BIOCHEMIC CO. LTD , https://www.medicine-voice.com